Clinical Characteristics of Polypoidal Choroidal Vasculopathy Associated with Chronic Central Serous Chorioretionopathy by Park, Han Sang & Kim, In Taek
15
pISSN: 1011-8942  eISSN: 2092-9382
Korean J Ophthalmol 2012;26(1):15-20
http://dx.doi.org/10.3341/kjo.2012.26.1.15
Original Article
Clinical Characteristics of Polypoidal Choroidal Vasculopathy 
Associated with Chronic Central Serous Chorioretionopathy
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Typical central serous chorioretinopathy (CSC) is char-
acterized by acute-onset serous retinal detachment as well 
as a benign visual prognosis with the self-resolution of 
retinal detachment after several months. Chronic CSC, 
which is defined as a persistent serous retinal detachment 
or recurrent multifocal detachments, may lead to diffuse 
decompensation of the retinal pigment epithelium (RPE), 
gradual multifocal RPE leakage with fluorescein angiog-
raphy (FAG), and finally a poor visual outcome due to the 
atrophic retina and RPE [1-10]. 
Chronic CSC, which is also known as diffuse retinal 
pigment epitheliopathy, shows specific retinal changes 
such as multiple RPE atrophies, RPE hyperpigmentations, 
and gravitational atrophic RPE tracts. As the indocya-
nine green angiography (ICGA) of the CSC demonstrated 
several choroidal findings such as choroidal hyperperme-
ability, choroidal lobular ischemia and choroidal venous 
congestion, it is accepted that the pathogenesis of CSC is 
associated with the dysfunction of choroidal vessels [9-15]. 
Polypoidal choroidal vasculopathy (PCV) is characterized 
by a branching vascular network (BVN) with terminal 
polypoidal dilations. Many studies on PCV have been 
conducted in Asian countries since the incidence of PCV 
is relatively high in Asians [16-18]. PCV is reported to 
originate from inner choroidal vessel abnormalities similar 
to that of CSC, and PCV also has a specific ICGA finding 
of CSC, which is known as choroidal hyperpermeability. 
It thus appears that the pathogeneses of these two diseases 
have some common features [19,20]. A history of CSC was 
actually found to be more prevalent in PCV in a study of 
the relationship between a past history of CSC and the 
onset incidences of PCV or typical age-related macular 
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Purpose: To investigate the clinical characteristics of polypoidal choroidal vasculopathy (PCV) associated with 
chronic central serous chorioretinopathy (CSC).
Methods: We retrospectively reviewed the medical records of 246 PCV patients (283 eyes) between July 2004 
and August 2009 and investigated the clinical characteristics of the PCV patients who had specific fundus 
findings of chronic CSC.
Results: Among PCV patients, 13 eyes (4.6%) of 13 PCV patients (5.3%) had fundus findings of chronic CSC. All 
of the PCV lesions had a solitary polyp located outside the atrophic retina, predominantly in the macular area 
(84.6%), most showed an exudative pattern (69.2%) and there were a few that showed a hemorrhagic pattern 
(30.8%). All of the lesions were smaller than 1 disc diameter. Most of the PCV lesions (76.9%) were cured with 
less than two treatments in a short period of 6.4 ± 1.9 months; however, visual acuity deteriorated (61.5%) or 
was not changed (30.8%) in most of the cases.
Conclusions: The PCV associated with chronic CSC had several clinical features such as a small exudative 
retinal lesion with a solitary polyp and frequent involvement of the macular area. Even though there was poor 
visual outcome due to the atrophic change, all of the PCV lesions were easily resolved in a short period with a 
simple treatment course and no recurrence.
Key Words: Chronic central serous chorioretinopathy, Indocyanine green angiography, Polypoidal choroidal 
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degeneration (AMD). Moreover, specific funduscopic find-
ings of CSC, like atrophic RPE tract or focal photocoagu-
lation scars, were found more frequently in PCV [21]. 
We retrospectively review the medical records of pa-
tients with PCV associated with chronic CSC and investi-
gated the clinical characteristic of these PCV patients.
Materials and Methods
We retrospectively reviewed the medical records of 246 
PCV patients, for a total of 283 eyes, who had visited our 
clinic (Kyungpook National University Hospital) between 
July 2004 and August 2009. We extracted the PCV patients 
that had specific fundus findings of chronic CSC and then 
investigated the clinical characteristics of these PCV pa-
tients. All of the PCV patients underwent a comprehensive 
ophthalmic examination, that included Snellen visual acu-
ity, biomicroscopy, fundus photography, FAG, ICGA (HRA 
system; Heidelberg Engineering, Heidelberg, Germany), 
and optical coherence tomography (OCT; Stratus OCT or 
Cirrus OCT, Carl Zeiss Meditec, Dublin, CA, USA). 
Chronic CSC was objectively diagnosed based on the 
presence of specific fundus findings like an atrophic RPE 
tract, multiple RPE atrophies and an FAG finding showing 
hypofluorescence due to a window defect or partial hyper-
fluorescence due to a leak from diffuse RPE decompensa-
tion. We confirmed an atrophic lesion as chronic CSC with 
the exclusion of AMD or PCV with ICGA in cases with a 
small leakage area of FAG.
The clinical diagnosis of PCV in older patients was 
made on the basis of the fundus and ICGA findings. The 
hemorrhagic or exudative lesion was typically diagnosed 
as PCV based on the presence of the BVN with single or 
multiple polyp-like terminal dilations in ICGA and an 
elevated red-orange finding in the fundus. The diagnosis 
of PCV also included the presence of polyp-like terminal 
dilations, which was a distinctive finding of PCV, without 
identifiable BVN or an elevated red-orange lesion. All of 
the patients were interviewed on their histories of systemic 
disease such as hypertension, diabetes mellitus or other 
retinal diseases that were also evaluated in the other eye of 
the patient. 
Fundus findings were classified as one of two patterns, 
either as an exudative pattern or a hemorrhagic pattern. In 
the exudative pattern, serous pigment epithelium detachment 
(PED) and/or retinal detachment was predominant with little 
or no hemorrhage. In the hemorrhagic pattern, the hemor-
rhagic PED and/or submacular hemorrhage were predominant 
in the lesion. The polyp location and the polyp configuration 
were identified with ICGA. The polyp location was evaluated 
on the basis of the locations of the disc and fovea. There were 
two types of polyp configurations, the solitary type and the 
cluster type that is composed of more than two polyps [22]. 
We also evaluated the polyp location compared to the location 
of the atrophic retina of chronic CSC and whether the polyps 
were involved in a single area or in multiple areas of the 
fundus. The number and method of treatments as well as 
when the lesion state reached a stable condition after treat-
ment were also investigated.
Results
Among 283 eyes of 246 PCV patients, 13 eyes (4.6%) of 
13 patients (5.3%) (right eye, 9 [69.2%]; left eye, 4 [30.8%]) 
had specific fundus findings of chronic CSC (Table 1). The 
mean age of PCV onset was 69.8 ± 6.2 years (range, 55 to 
79 years), and 11 (84.6%) of the patients were men. The 
overall duration of follow-up after PCV onset was 27.0 ± 
18.4 months (range, 6 to 64 months). The resolution of the 
PCV lesion took 6.4 ± 1.9 months (range, 4 to 10 months) 
through various treatments after PCV onset, and there 
were no recurrences after the resolution of PCV for 20.0 ± 
17.7 months (range, 1 to 55 months). Of these 13 PCV pa-
tients, three had hypertension and none of them had diabe-
tes. All of the patients were unilaterally affected with PCV, 
but 11 (84.6%) of the 13 patients also had specific fundus 
findings of chronic CSC in their fellow eyes.
Eleven polypoidal lesions (84.6%) in ICGA were located 
in the macular area, which were all within 0.5 disc diam-
eters (DD) from the fovea (Fig. 1), and two of the lesions 
(15.4%) were in the peripapillary area, within 0.5 DD from 
the margin of the optic disc (Fig. 2). The exudative pattern 
was found in the fundus in nine of the patients (69.2%), 
and the hemorrhagic pattern was found in four of the pa-
tients (30.8%). Among the four eyes with the hemorrhagic 
pattern, only two (15.4%) had a definite hemorrhagic PED. 
Most of the lesions in the other two eyes were composed 
of exudative lesions, and there was only a small amount of 
retinal hemorrhage in the larger area of exudative lesion. 
The sizes of all of the lesions, regardless of their pattern, 
were less than 1 DD in area, and none of the lesions had 
extensive hemorrhage or exudation. All 13 eyes had a soli-
tary polyp configuration. A prominent BVN could not be 
found near any of the polyps, even though large choroidal 
vessels were easily found in the atrophic area around the 
polyp in all of the eyes. The ICGA findings showed that 
three of 13 patients had polyps that were involved in mul-
tiple areas of the fundus, and the other 10 patients (76.9%) 
had a single area of PCV involvement. In regard to the 
location of a polyp compared to the atrophic retinal area, 
there were no polyps that were identified within the atro-
phic retina of the chronic CSC lesion or distant from the 
atrophic retina. All of the polyps were located around the 
boundary of the atrophic retina and were identified within 
0.5 DD of the normal retina from the boundary of the atro-
phic retina. 
Various treatments such as intravitreal ranibizumab in-
jection, intravitreal bevacizumab injection, photodynamic 17
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Table 1. Clinical data of patients with polypoidal choroidal vasculopathy
Patient / 
















1 / F / 79 L CSC Macular Single  Exudative  PDT 2 1 1
2 / M / 64 R CSC HTN Macular Single  Exudative  IVR 1 0.52 1
3 / M / 68 R CSC Macular Single  Exudative  IVR 1 0.7 1
4 / M / 72 L CSC Macular Single  Exudative  PDT 1 0.3 0.4
5 / F / 70 R CSC Macular Single  Hemorrhage PHC 1, IVR 1 0.52 1.3
6 / M / 68 L Macular Multi  Exudative  IVR 1 0.22 0.2
7 / M / 66 R CSC Papillary Single  Exudative  PHC 1 0.7 0.7
8 / M / 77 R CSC Macular Single  Exudative  PDT 2, IVB 1 0.4 0.7
9 / M / 55 R CSC HTN Macular Single  Hemorrhagic 
PED
Self resolution  0.52 0
10 / M / 72 R CSC HTN Macular Multi  Exudative  PDT 1, IVB 3 0.3 1
11 / M / 75 R CSC Papillary Multi  Hemorrhage PDT 1, IVB 1 0.16 0.7
12 / M / 73 L CSC Macular Single  Hemorrhagic 
PED
PDT 1 0.52 1
13 / M / 69 R Macular Single  Exudative  IVB 1 0.22 0.2
CSC = central serous chorioretinopathy; BCVA = best-corrected visual acuity; PCV = polypoidal choroidal vasculopathy; HTN = hyper-
tension; PDT = photodynamic therapy; IVR = intravitreal ranibizumab injection; IVB = intravitreal bevacizumab injection; PHC = con-
ventional laser photocoagulation; PED = pigment epithelium detachment.
*BCVA in logarithm of the minimum angle of resolution acuity.
Fig. 1. A 73-year-old man (case 12) with a polypoidal choroidal 
vasculopathy lesion in the submacular hemorrhagic lesion. (A) 
In fundus photography, an atrophic retinal pigment epithelium 
(RPE) tract and a submacular hemorrhage were found in the 
macular area and (B,C) a fluorescein angiography and an in-
docyanine green angiography (ICGA) showed a solitary polyp 
near the atrophic RPE tract. (D) Optical coherence tomography 
showed pigment epithelial detachment in the polypoidal lesion 
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therapy, and conventional laser photocoagulation were 
conducted. Including the one patient whose retinal detach-
ment was absorbed without treatment, the average number 
of treatments was 1.53 (0 to 4), and 10 cases had complete 
resolution within two treatments (76.9%). The mean best-
corrected visual acuity (BCVA) at presentation of PCV 
was 0.47 ± 0.24 (0.16 to 1) with the conversion to logarithm 
of the minimum angle of resolution, and the mean final 
BCVA after the complete resolution of the PCV lesion was 
0.71 ± 0.39 (0 to 1.3). All of the PCV lesions were cured 
into the atrophic state without fibrotic scar tissue. 
Discussion
The abnormalities of inner choroidal vessels have been 
introduced as the primary pathogenesis of both CSC and 
PCV in a number of studies. In the ICGA studies of CSC, 
a diffuse choroidal hyperpermeability was considered as 
a main pathogenesis of CSC. In the pathogenesis model of 
CSC, diffuse choroidal hyperpermeability causes blister 
elevations (serous RPE detachments). Increasing choroidal 
pressure mechanically induces RPE tearing or RPE de-
compensation, which finally results in RPE leakage into 
the subretinal space and a neurosensory detachment (serous 
retinal detachment) [1-8]. This similar pathogenesis was 
also proposed in the pathologic finding of PCV. In a recent 
study of PCV pathology, the primary pathologic finding 
of PCV was reported as dilated hyalinized choroidal ves-
sels followed by a massive extravasation of plasma protein 
into the choroidal tissue without granulation. This also 
included tissue proliferation, which is also found in choroi-
dal neovascularization, and massive exudation induced by 
abnormal choroidal vesssels can sufficiently increase the 
choroidal tissue pressure to produce the protrusion of cho-
roidal tissues through the weak area of RPE and Bruch’s 
membrane. In this study, arteriosclerotic changes of the 
choroidal vessels were proposed as the main pathogenesis 
of these pathologic findings [23].
The mutual correlation of pathogenesis between PCV 
and CSC has been proposed [24], which suggests the pos-
sibility that the RPE changes in chronic CSC might pre-
dispose one to polypoidal changes of choroidal vessels. 
Another PCV study reported that the choroidal vascular 
hyperpemeability, which was the characteristic ICGA 
finding of CSC, was more prevalent in PCV than in typi-
cal AMD (9.8% vs. 1.9%), and other ICGA findings of 
CSC, such as choroidal filling delay and a dilated choroidal 
Fig. 2. A 66-year-old man (case 7) with a polypoidal choroidal 
vasculopathy lesion around the peripapillary area. (A) Fluorescein 
angiography (FAG) showed atrophic lesions corresponding to an 
atrophic retinal pigment epithelium tract and the atrophic lesion in 
the superior peripapillary area. The polypoidal lesion was found 
near the superior atrophic lesion. (B) indocyanine green angiogra-
phy (ICGA) also showed a solitary polyp in the polypoidal lesion 
of the FAG. (C) Optical coherence tomography showed the pigment 
epithelium detachment (white arrow) in the polypoidal lesion of the 
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vein, were more common in PCV as well [20]. The direct 
correlation between PCV onset and a history of CSC was 
recently investigated [21]. In a study of PCV in Japan, 
which compared the background factor of PCV and typical 
AMD, a past history of CSC was more frequently found 
in PCV patients than in AMD patients (14.7% vs. 3.4%). 
In a study on objective fundus findings that more likely 
suggested a history of CSC, an atrophic RPE tract and fo-
cal photocoagulation scars were more frequently found in 
PCV patients than in AMD patients (7.6% vs. 0.7%). 
We also investigated FAG, ICGA and fundus findings, 
such as the RPE atrophic tract, and multiple RPE atrophies 
in order to objectively study the clinical findings of PCV 
associated with chronic CSC. Among 283 eyes of 246 
PCV patients, PCV onset with specific fundus findings 
of chronic CSC occurred in 13 eyes (4.6%) of 13 patients 
(5.3%). This rate was similar to that reported in the Ueta 
study, which disclosed that 11 patients (6.5%) had a RPE 
atrophic scar without photocoagulation scars of 170 PCV 
patients [21]. In the current study, many patients (11 pa-
tients, 84.6%) also had fundus findings of chronic CSC in 
their other eye, but none of the patients had PCV lesions in 
both eyes. 
PCV lesions were most frequently located in the macular 
area in the PCV studies of Koreans. One PCV study in Ko-
rea reported that the PCV lesions in ICGA were located in 
the macula (87.8%), in the peripapillary area (5%), and in 
both macula and peripapillary area (7.2%). Another PCV 
study reported that these types of lesions were located in 
the macula (62.5%), in the peripapillary area (7.5%), and in 
both macula and peripapillary area (6.3%) [17,25]. Also, the 
macular area was most frequently involved with the PCV 
lesion (84.6%) in the current study. 
When we investigated the polyp location in relation to 
the atrophic retina of chronic CSC, all of the polyps were 
outside the boundary of the atrophic retina. There was no 
polypoidal appearance within the atrophic retina. We pos-
tulated that, in a severely atrophied retina, a polyp cannot 
be produced due to severe atrophy of all of the chorodial 
vessels, including the choriocapillaris and the choroidal 
artery/vein, which would cause them to lose their ability to 
dilate and protrude. It is believed that the reason why pol-
yps were not found in the distant area was due to the fact 
that the distant retina would have little risk of PCV occur-
rence since this area would contain less damaged choroidal 
vessels, which were less influenced by the chronic CSC 
due to the far distance. 
In the current study, the PCV lesion had a small sized 
lesion of less than 1 DD in area that did not have either ex-
tensive hemorrhage or exudation. Most of the patients had 
the exudative pattern (9 eyes, 69.2%), and two of the four 
patients with the hemorrhagic pattern had larger exuda-
tive lesions than hemorrhage lesions in their PCV lesions. 
In regard to the polyp configuration of the current study, 
all of the polyps were of the solitary type even in the cases 
that had polyps that were identified in multiple areas of 
the ICGA. In contrast to the current study, previous PCV 
studies on Koreans reported that cases with a hemorrhagic 
pattern and cluster type polyps were more prevalent than 
cases with the exudative pattern. One report showed that 
the hemorrhagic pattern occurred in 61.3% of cases, which 
included an extensive hemorrhage, and cluster type polyps 
accounted for 74.5%, which included polyps with a micro-
aneurysm and a large aneurysm, and another study showed 
that subretinal hemorrhage occurred in 63.8% of cases 
and cluster type polyps occurred in 60% of cases [17,25]. 
This difference between the fundus findings of the current 
study and of previous studies may have been due to the 
generalized atrophied choroidal tissue, including the ves-
sels, not leading to active PCV lesions as in an extensive 
BVN or a cluster of polyps, even though the predisposition 
of PCV occurrence would increase due to the choroidal 
vascular abnormality of the chronic CSC. 
A study on the natural history of PCV has reported that 
a solitary polyp that is usually stable with favorable clini-
cal course will tend to regress and disappear, and that a 
cluster of polyps in an active lesion, which has a high risk 
factor indicative of hemorrhage and leakage, had a worse 
prognosis. They also reported that the hemorrhagic pattern 
had repeated recurrences of acute bleeding that caused a 
sudden decrease in visual acuity, and that the exudative 
pattern that is associated with intraretinal lipid deposits 
maintained a similar exudation for a long period of time, 
which was then followed by degeneration and atrophy of 
the RPE that then led to the decrease in visual acuity [22]. 
Similar to a previous study, all of the PCV lesions in the 
current study had a solitary polyp that maintained a stable 
state without active bleeding or recurrence, and most of 
the PCV lesions had the exudative pattern that produced 
an atrophic retina and choroid. Actually, all of the lesions 
in our study were more atrophied after the resolution of 
the PCV lesion even in those with the hemorrhagic pattern, 
which was partially due to the generalized atrophic retinal 
state due to the chronic CSC. 
To the complete resolution of the PCV lesion after treat-
ment, the follow-up period was slightly short at 6.4 ± 1.9 
months (4 to 10 months), and in 10 of the cases (76.9%), 
including one self-resolution case, the PCV lesions were 
cured with less than two courses of treatment. None of the 
PCV lesions in the current study required surgery for mas-
sive hemorrhage or a complicated course of treatments; we 
assumed that this was because the lesions had an inactive 
character like a solitary polyp, a small sized exudative le-
sion or a generalized atrophic retina without highly active 
lesions like a cluster of polyps or a large BVN. 
However, there was no change in four eyes (30.8%) in re-
gard to the visual acuity, and eight eyes (61.5%) worsened 
in visual acuity, which means that this was more common 20
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an occurrence than an improvement in visual acuity, which 
only occurred in one eye (7.7%). We believed the worsened 
visual acuity was induced by the atrophic damage from 
the PCV lesion in the macular area, which was the most 
common site of the PCV occurrence (84.6%). 
A benefit of the current study is that it used more objec-
tive fundus findings, which are more likely to suggest a 
history of chronic CSC, but also has the limitation in that 
the study could not investigate the longstanding disease 
course from the onset of typical acute CSC. Other limita-
tions of this study are the small number of patients en-
rolled and the short follow-up time of some of the cases. 
In conclusion, the PCV lesion associated with chronic 
CSC has several clinical characteristics. Most of the PCV 
lesions had a solitary polyp, which was found in multiple 
lesions in some of the cases, and there were no cluster of 
polyps or large BVN observed. The exudative retinal lesion 
with little or no hemorrhage was the most common retinal 
finding, and the macular area was the most common site 
of PCV occurrence. All of the polyps were located within 
0.5 DD outside the boundary of the atrophic lesion. Visual 
acuities in most of the cases were deteriorated, and we 
guessed this was due to the atrophic damage caused by the 
PCV lesion occurring in the macular area. However, there 
was no need for the multiple and complicated treatment 
courses of these patients, and all of the PCV lesions were 
easily resolved to an atrophic state within a short period 
of time and maintained a stable state without recurrence 
throughout the follow-up period. 
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